01 junio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Incidence and Clinical Outcomes of Stent Fractures on the Basis of 6,555 Patients and 16,482 Drug-Eluting Stents From 4 Centers

Jing Kan, MBBSa; Zhen Ge, MDa; Jun-Jie Zhang, PhDa; Zhi-Zhong Liu, PhDa; Nai-Liang Tian, MDa; Fei Ye, MDa; Sui-Ji Li, MDb; Xue-Song Qian, MDc; Song Yang, MDd; Meng-Xuan Chen, MBBSe; Tanveer Rab, MDf; Shao-Liang Chen, MDa

Objectives: The present study aimed to analyze the incidence of SF and its correlation with clinical events after DES implantation and the outcome of re-intervention for symptomatic in-stent restenosis (ISR) induced by stent fracture (SF).

01 junio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. 1-Year Results of the REMEDEE Registry. Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry

Pier Woudstra, MDa; Deborah N. Kalkman, MDa; Peter den Heijer, MD, PhDb; Ian B.A. Menown, MDc; Andrejs Erglis, MDd; Harry Suryapranata, MD, PhDe; Karin E. Arkenbout, MD, PhDf; Andrés Iñiguez, MD, PhDg; Arnoud W.J. van ´t Hof, MD, PhDh; Philippe Muller, MDi; Jan G.P. Tijssen, PhDa; Robbert J. de Winter, MD, PhDa

Objectives: This registry evaluated the safety and clinical outcomes of the Combo stent in an all-comers population in routine clinical practice. We report 1-year results.

01 junio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Feasibility and Safety of Unzipping Small Diameter Stents in the Blood Vessels of Piglets

Shyam K. Sathanandam, MDa; T.K. Susheel Kumar, MDb; Deepthi Hoskoppal, MDc; Lauren M. Haddad, MDa; Saradha Subramanian, MDa; Ryan D. Sullivan, DVMd; David Zurakowski, PhDe; Christopher Knott-Craig, MDb; B. Rush Waller, III, MDa

Objectives: This study sought to determine the feasibility and safety of unzipping small-diameter stents (SDS) in a growing animal model.

01 junio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Choice of Treatment for Aortic Valve Stenosis in the Era of Transcatheter Aortic Valve Replacement in Eastern Denmark (2005 to 2015)

Ole De Backer, MD, PhDa; Ngai H.V. Luk, MDa; Niels T. Olsen, MD, PhDa; Peter S. Olsen, MD, DMScb; Lars Søndergaard, MD, DMSca

Objectives: The aim of this study was to evaluate the choice of treatment for severe aortic valve stenosis in the era of transcatheter aortic valve replacement (TAVR) in Eastern Denmark.

01 junio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Percutaneous Transvenous Transseptal Transcatheter Valve Implantation in Failed Bioprosthetic Mitral Valves, Ring Annuloplasty, and Severe Mitral Annular Calcification

Mackram F. Eleid, MDa; Allison K. Cabalka, MDa; Matthew R. Williams, MDb; Brian K. Whisenant, MDc; Oluseun O. Alli, MDd; Neil Fam, MDe; Peter M. Pollak, MDa; Firas Barrow, MDb; Joseph F. Malouf, MDa; Rick A. Nishimura, MDa; Lyle D. Joyce, MD, PhDa; Joseph A. Dearani, MDa; Charanjit S. Rihal, MD, MBAa

Objectives: This study sought to examine the feasibility, safety, and intermediate-term outcomes in patients undergoing percutaneous transvenous transcatheter mitral valve implantation in failed bioprosthesis, ring annuloplasty, and calcific mitral stenosis.

01 junio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Stent Thrombosis With Drug-Eluting Stents and Bioresorbable Scaffolds. Evidence From a Network Meta-Analysis of 147 Trials

Si-Hyuck Kang, MDa; In-Ho Chae, MD, PhDa; Jin-Joo Park, MD, PhDa; Hak Seung Lee, MDb; Do-Yoon Kang, MDc; Seung-Sik Hwang, MD, PhDd; Tae-Jin Youn, MD, PhDa; Hyo-Soo Kim, MD, PhDb

Objectives: This study sought to perform a systematic review and network meta-analysis to compare the relative safety and efficacy of contemporary DES and BVS.

01 junio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents. Intravascular Ultrasound Assessment From the ABSORB II Trial

Yohei Sotomi, MDa; Yuki Ishibashi, MD, PhDb; Pannipa Suwannasom, MDa,b,c; Shimpei Nakatani, MDb; Yun-Kyeong Cho, MD, PhDb; Maik J. Grundeken, MDa; Yaping Zeng, MD, PhDb; Hiroki Tateishi, MD, PhDb; Pieter C. Smits, MD, PhDd; Paul Barragan, MD, PhDe; Ran Kornowski, MDf; Anthony H. Gershlick, MD, PhDg; Stephan Windecker, MD, PhDh; Robert-Jan van Geuns, MD, PhDb; Antonio L. Bartorelli, MD, PhDi; Robbert J. de Winter, MD, PhDa; Jan Tijssen, MD, PhDa; Patrick W. Serruys, MD, PhDj; Yoshinobu Onuma, MD, PhDb

Objectives: The study compared, by intravascular ultrasound (IVUS), acute gain (AG) at the site of the pre-procedural minimal lumen area (MLA) achieved by either the Absorb (Abbott Vascular, Santa Clara, California) scaffold or the Xience stent and identified the factors contributing to the acute performance of these devices.

01 junio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial

Pannipa Suwannasom, MDa,b,c; Yohei Sotomi, MDb; Yuki Ishibashi, MD, PhDa; Rafael Cavalcante, MD, PhDa; Felipe N. Albuquerque, MDd; Carlos Macaya, MDe; John A. Ormiston, MDf; Jonathan Hill, MDg; Irene M. Lang, MDh; Mohaned Egred, MDi; Jean Fajadet, MDj; Maciej Lesiak, MDk; Jan G. Tijssen, MD, PhDb; Joanna J. Wykrzykowska, MD, PhDb; Robbert J. de Winter, MD, PhDb; Bernard Chevalier, MDl; Patrick W. Serruys, MD, PhDm; Yoshinobu Onuma, MD, PhDa

Objectives: The study sought to investigate the relationship between post-procedural asymmetry, expansion, and eccentricity indices of metallic everolimus-eluting stent (EES) and bioresorbable vascular scaffold (BVS) and their respective impact on clinical events at 1-year follow-up.

01 junio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis. 3-Year Follow-Up of the RIBS V Clinical Trial

Fernando Alfonso, MDa; María José Pérez-Vizcayno, MDb,c; Bruno García del Blanco, MDd; Imanol Otaegui, MDd; Mónica Masotti, MDe; Javier Zueco, MDf; Maite Veláquez, MDg; Juan Sanchís, MDh; Arturo García-Touchard, MDi; Rosa Lázaro-García, MDj; José Moreu, MDk; Armando Bethencourt, MDl; Javier Cuesta, MDa; Fernando Rivero, MDa; Alberto Cárdenas, MDc; Nieves Gonzalo, MDc; Pilar Jiménez-Quevedo, MDc; Cristina Fernández, MDc

Objectives: The aim of this study was to compare the long-term efficacy of everolimus-eluting stents (EES) and drug-eluting balloons (DEB) in patients with bare-metal stent in-stent restenosis (ISR).

01 junio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Intracoronary Brachytherapy for Recurrent Drug-Eluting Stent Failure

Smita I. Negi, MD; Rebecca Torguson, MPH; Jiaxiang Gai, MSPH; Sarkis Kiramijyan, MD; Edward Koifman, MD; Rosanna Chan, PhD; Pamela Randolph, MD; Augusto Pichard, MD; Lowell F. Satler, MD; Ron Waksman, MD

Objectives: The study sought to report safety and long-term clinical efficacy of intravascular brachytherapy (VBT) for recurrent drug-eluting stent in-stent restenosis (DES-ISR).

01 junio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. The Electrocardiogram After Transcatheter Aortic Valve Replacement Determines the Risk for Post-Procedural High-Degree AV Block and the Need for Telemetry Monitoring

Stefan Toggweiler, MDa; Stefan Stortecky, MDb; Erik Holy, MDc; Katarzyna Zuk, MDb; Florim Cuculi, MDa; Fabian Nietlispach, MDc; Zaid Sabti, MDa; Raluca Suciu, MDc; Willibald Maier, MDc; Peiman Jamshidi, MDa; Francesco Maisano, MDc; Stephan Windecker, MDb; Richard Kobza, MDa; Peter Wenaweser, MDb; Thomas F. Lüscher, MDc; Ronald K. Binder, MDc

Objectives: The study sought to identify predictors for delayed high-degree atrioventricular block (AVB) in patients undergoing transcatheter aortic valve replacement (TAVR) and determine the need and required duration of telemetry monitoring.

01 junio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Transcatheter Procedure for Residual Mitral Regurgitation After MitraClip Implantation Using Amplatzer Duct Occluder II

Shunsuke Kubo, MD; Justin M. Cox, MD; Yukiko Mizutani, MD; Abhimanyu Uberoi, MD; Tarun Chakravarty, MD; Yoshifumi Nakajima, MD; Asma Hussaini, PA; Emily Tat, BA; Moody Makar, MD; Saibal Kar, MD

Objectives: This study reports a novel transcatheter procedure for residual mitral regurgitation (MR) after MitraClip implantation using the Amplatzer Duct Occluder II (ADO II).

01 julio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Effect of Post–Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Acute Stent Thrombosis. Meta-Analysis of Randomized Controlled Trials

Rahman Shah, MDa,b; Kelly C. Rogers, PharmDb,c; Agha J. Ahmed, MDd; Bryan J. King, MDa,b; Sunil V. Rao, MDe

Objectives: The aim of this study was to evaluate the efficacy of various doses of post–primary percutaneous coronary intervention (PCI) bivalirudin infusion to prevent acute stent thrombosis (AST).

01 julio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Percutaneous Coronary Interventions for the Treatment of Stenoses in Small Coronary Arteries. A Network Meta-Analysis

George C.M. Siontis, MD, PhDa; Raffaele Piccolo, MDa; Fabien Praz, MDa; Marco Valgimigli, MDa; Lorenz Räber, MD, PhDa; Dimitris Mavridis, PhDb; Peter Jüni, MDc; Stephan Windecker, MDa

Objectives: This study evaluated the most appropriate percutaneous coronary intervention (PCI) for the treatment of stenoses in small coronary arteries.

01 julio 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Dedicated Bifurcation Stent for the Treatment of Bifurcation Lesions Involving Large Side Branches. Outcomes From the Tryton Confirmatory Study

Philippe Généreux, MDa,b,c; Indulis Kumsars, MDd; Joel E. Schneider, MDe; Maciej Lesiak, MDf; Björn Redfors, MD, PhDa; Kristoff Cornelis, MDg; Matthew R. Selmon, MDh; Jo Dens, MD, PhDi; Angela Hoye, MDj; D. Christopher Metzger, MDk; Luc Muyldermans, MDl; Ton Slagboom, MDm; Dominic P. Francese, MPHa; Girma Minalu Ayele, PhDa; Linda L. Laak, BSNn; Antonio L. Bartorelli, MDo; Donald E. Cutlip, MDp; Aaron V. Kaplan, MDn,q; Martin B. Leon, MDa,b

Objectives: The aim of this study was to prospectively study and confirm the safety and efficacy of the Tryton Side Branch Stent in the treatment of coronary artery bifurcations involving large side branches (SBs).